|
1
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balkwill F: Chemokine biology in cancer.
Semin Immunol. 15:49–55. 2003. View Article : Google Scholar
|
|
4
|
Strieter RM, Burdick MD, Mestas J,
Gomperts B, Keane MP and Belperio JA: Cancer CXC chemokine networks
and tumour angiogenesis. Eur J Cancer. 42:768–778. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zlotnik A: Chemokines in neoplastic
progression. Semin Cancer Biol. 14:181–185. 2004. View Article : Google Scholar
|
|
6
|
Luster AD and Ravetch JV: Biochemical
characterization of a gamma interferon-inducible cytokine (IP-10).
J Exp Med. 166:1084–1097. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dwinell MB, Johanesen PA and Smith JM:
Immunobiology of epithelial chemokines in the intestinal mucosa.
Surgery. 133:601–607. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horuk R: Chemokine receptors. Cytokine
Growth Factor Rev. 12:313–335. 2001. View Article : Google Scholar
|
|
9
|
Romagnani P and Crescioli C: CXCL10: a
candidate biomarker in transplantation. Clin Chim Acta.
413:1364–1373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu M, Guo S, Hibbert JM, Jain V, Singh N,
Wilson NO and Stiles JK: CXCL10/IP-10 in infectious diseases
pathogenesis and potential therapeutic implications. Cytokine
Growth Factor Rev. 22:121–130. 2011.PubMed/NCBI
|
|
11
|
Dwinell MB, Lugering N, Eckmann L and
Kagnoff MF: Regulated production of interferon-inducible T-cell
chemoattractants by human intestinal epithelial cells.
Gastroenterology. 120:49–59. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Verbeke H, Struyf S, Laureys G and Van
Damme J: The expression and role of CXC chemokines in colorectal
cancer. Cytokine Growth Factor Rev. 22:345–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang Z, Xu Y and Cai S: CXCL10 expression
and prognostic significance in stage II and III colorectal cancer.
Mol Biol Rep. 37:3029–3036. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Toiyama Y, Fujikawa H, Kawamura M,
Matsushita K, Saigusa S, Tanaka K, Inoue Y, Uchida K, Mohri Y and
Kusunoki M: Evaluation of CXCL10 as a novel serum marker for
predicting liver metastasis and prognosis in colorectal cancer. Int
J Oncol. 40:560–566. 2012.PubMed/NCBI
|
|
15
|
Venturelli E, Galimberti D, Fenoglio C,
Lovati C, Finazzi D, Guidi I, Corra B, Scalabrini D, Clerici F,
Mariani C, Forloni G, Bresolin N and Scarpini E: Candidate gene
analysis of IP-10 gene in patients with Alzheimer’s disease.
Neurosci Lett. 404:217–221. 2006.PubMed/NCBI
|
|
16
|
Galimberti D, Scalabrini D, Fenoglio C,
Comi C, De Riz M, Venturelli E, Lovati C, Mariani C, Monaco F,
Bresolin N and Scarpini E: CXCL10 haplotypes and multiple
sclerosis: association and correlation with clinical course. Eur J
Neurol. 14:162–167. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stetler-Stevenson WG: The role of matrix
metalloproteinases in tumor invasion, metastasis, and angiogenesis.
Surg Oncol Clin N Am. 10:383–392. 2001.PubMed/NCBI
|
|
18
|
Murray GI, Duncan ME, O’Neil P, Melvin WT
and Fothergill JE: Matrix metalloproteinase-1 is associated with
poor prognosis in colorectal cancer. Nat Med. 2:461–462. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zipin-Roitman A, Meshel T, Sagi-Assif O,
Shalmon B, Avivi C, Pfeffer RM, Witz IP and Ben-Baruch A: CXCL10
promotes invasion-related properties in human colorectal carcinoma
cells. Cancer Res. 67:3396–3405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Asano T, Tada M, Cheng S, Takemoto N,
Kuramae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T and
Kondo S: Prognostic values of matrix metalloproteinase family
expression in human colorectal carcinoma. J Surg Res. 146:32–42.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Al-Sohaily S, Biankin A, Leong R,
Kohonen-Corish M and Warusavitarne J: Molecular pathways in
colorectal cancer. J Gastroenterol Hepatol. 27:1423–1431. 2012.
View Article : Google Scholar
|
|
22
|
Yeruva S, Ramadori G and Raddatz D:
NF-kappaB-dependent synergistic regulation of CXCL10 gene
expression by IL-1beta and IFN-gamma in human intestinal epithelial
cell lines. Int J Colorectal Dis. 23:305–317. 2008. View Article : Google Scholar : PubMed/NCBI
|
